mAbs, Volume 2, Issue 6 (2010)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

mAbs, Volume 2, Issue 6 (2010)

See all volumes and issues
Vol 16, 2024 Vol 15, 2023 Vol 14, 2022 Vol 13, 2021 Vol 12, 2020 Vol 11, 2019 Vol 10, 2018 Vol 9, 2017 Vol 8, 2016 Vol 7, 2015 Vol 6, 2014 Vol 5, 2013 Vol 4, 2012 Vol 3, 2011 Volume 2, 2010 Vol 1, 2009
Download citations Download PDFs Download issue

Editorial

Editorial
Progress at mAbs
Janice M. Reichert
Page: 593
Published online: 01 Nov 2010
CitationforProgress at mAbs | Full Text | PDF (169.4 KB)
  • 464 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Therapeutic antibodies directed at G protein-coupled receptors
Catherine J. Hutchings, Markus Koglin & Fiona H. Marshall
Pages: 594-606
Published online: 01 Nov 2010
AbstractforTherapeutic antibodies directed at G protein-coupled receptors | Full Text | References | PDF (988 KB)
  • 4402 Views
  • 124 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Antibody immunosuppressive therapy in solid organ transplant
Part II
Dusko Klipa, Nadim Mahmud & Nasimul Ahsan
Pages: 607-612
Published online: 01 Nov 2010
AbstractforAntibody immunosuppressive therapy in solid organ transplant | Full Text | References | PDF (837.9 KB)
  • 992 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Report

Article
Charge variants in IgG1
Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
Leslie A. Khawli, Sirj Goswami, Ryan Hutchinson, Zephania W. Kwong, Jihong Yang, Xiangdan Wang, Zhenling Yao, Alavattam Sreedhara, Tony Cano, Devin B. Tesar, Ihsan Nijem, David E. Allison, Pin Yee Wong, Yung-Hsiang Kao, Cynthia Quan, Amita Joshi, Reed J. Harris & Paul Motchnik
Pages: 613-624
Published online: 01 Nov 2010
AbstractforCharge variants in IgG1 | Full Text | References | PDF (2.3 MB)
  • 12413 Views
  • 327 CrossRef citations
  • 0Altmetric
Free Access
Article
Anti-TNFα domain antibody construct CEP-37247
Full antibody functionality at half the size
Robert D. Gay, Adam W. Clarke, Zehra Elgundi, Teresa Domagala, Raina J. Simpson, Nga B. Le, Anthony G. Doyle & Phil A. Jennings
Pages: 625-638
Published online: 01 Nov 2010
AbstractforAnti-TNFα domain antibody construct CEP-37247 | Full Text | References | PDF (2.8 MB)
  • 902 Views
  • 27 CrossRef citations
  • 0Altmetric
Open Access
Article
ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibody
Kirstin A. Zettlitz, Verena Lorenz, Karlheinz Landauer, Sabine Münkel, Andreas Herrmann, Peter Scheurich, Klaus Pfizenmaier & Roland Kontermann
Pages: 639-647
Published online: 01 Nov 2010
AbstractforATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibody | Full Text | References | PDF (1.8 MB)
  • 1528 Views
  • 47 CrossRef citations
  • 0Altmetric
Free Access
Article
Fluorescent Citrine-IgG fusion proteins produced in mammalian cells
Alexander K. Haas, Christoffer von Schwerin, Daniela Matscheko & Ulrich Brinkmann
Pages: 648-661
Published online: 01 Nov 2010
AbstractforFluorescent Citrine-IgG fusion proteins produced in mammalian cells | Full Text | References | PDF (2.9 MB) | Supplemental
  • 1220 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Functional mapping of the anti-idiotypic antibody anti-TS1 scFv using site-directed mutagenesis and kinetic analysis
Ann Erlandsson, Patrik Holm, Rozbeh Jafari, Torgny Stigbrand & Birgitta E. Sundström
Pages: 662-669
Published online: 01 Nov 2010
AbstractforFunctional mapping of the anti-idiotypic antibody anti-TS1 scFv using site-directed mutagenesis and kinetic analysis | Full Text | References | PDF (1,003.1 KB)
  • 567 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Perspective

Monoclonal antibody therapy in multiple sclerosis
Paradigm shifts and emerging challenges
Paulo Fontoura
Pages: 670-681
Published online: 01 Nov 2010
AbstractforMonoclonal antibody therapy in multiple sclerosis | Full Text | References | PDF (1,020.7 KB)
  • 1764 Views
  • 26 CrossRef citations
  • 0Altmetric
Free Access
Have we overestimated the benefit of human(ized) antibodies?
Daniel R. Getts, Meghann T. Getts, Derrick P. McCarthy, Emily ML Chastain & Stephen D. Miller
Pages: 682-694
Published online: 01 Nov 2010
AbstractforHave we overestimated the benefit of human(ized) antibodies? | Full Text | References | PDF (1.2 MB)
  • 1783 Views
  • 72 CrossRef citations
  • 0Altmetric
Open Access

Editor's Corner

Editorial
Metrics for antibody therapeutics development
Janice M. Reichert
Pages: 695-700
Published online: 01 Nov 2010
AbstractforMetrics for antibody therapeutics development | Full Text | References | PDF (714.1 KB)
  • 1531 Views
  • 63 CrossRef citations
  • 0Altmetric
Free Access
Editorial
2010 upcoming meetings
Janice M. Reichert
Page: 701
Published online: 01 Nov 2010
Citationfor2010 upcoming meetings | PDF (184.9 KB)
  • 104 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Rapid depletion of “catch-and-release” anti-ASGR1 antibody in vivo
Siva Charan Devanaboyina et al.
Report | Published online: 25 Jul 2024
Open Access
Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers
Bill Liao et al.
Report | Published online: 24 Jul 2024
Open Access
Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy
Patrizia Murer et al.
Report | Published online: 23 Jul 2024
Open Access
Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations
Joel Heisler et al.
Report | Published online: 19 Jul 2024
Open Access